Spire Healthcare Group (LON:SPI) Reaches New 52-Week High - Should You Buy?

Key Points

• Spire Healthcare Group's stock reached a new 52-week high of GBX 256.50 ($3.46) and last traded at GBX 247 ($3.33), with a trading volume of approximately 9.7 million shares.
• Analysts have given Spire Healthcare an average rating of "Buy," with a price target ranging from GBX 280 to GBX 303, indicating positive sentiment from investment firms.
• The company reported quarterly earnings of GBX 4.10 per share, with an anticipated annual earnings per share forecast of approximately 15.66 for the current fiscal year.

Spire Healthcare Group plc (LON:SPI - Get Free Report) reached a new 52-week high during trading on Saturday . The stock traded as high as GBX 256.50 ($3.46) and last traded at GBX 247 ($3.33), with a volume of 9747062 shares. The stock had previously closed at GBX 216.50 ($2.92).

Analyst Upgrades and Downgrades

Several research analysts have commented on the stock. Berenberg Bank reiterated a "buy" rating and set a GBX 280 price target on shares of Spire Healthcare Group in a report on Thursday, July 31st. JPMorgan Chase & Co. lowered their target price on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an "overweight" rating for the company in a report on Tuesday, August 5th. Three analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock presently has a consensus rating of "Buy" and a consensus target price of GBX 294.33.

Spire Healthcare Group Stock Performance

The firm's 50-day moving average is GBX 218.75 and its 200 day moving average is GBX 203.41. The stock has a market cap of £993.86 million, a PE ratio of 5,369.57, a P/E/G ratio of 1.06 and a beta of 0.96. The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70.

Spire Healthcare Group (LON:SPI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported GBX 4.10 EPS for the quarter. Spire Healthcare Group had a net margin of 1.96% and a return on equity of 3.82%. As a group, research analysts anticipate that Spire Healthcare Group plc will post 15.6634747 EPS for the current year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.